← feed

Is NCT02583451 results overdue?

Yes — results are overdue. Primary completion was 2017-01-31; the FDAAA-801 reporting deadline (2018-01-31) passed 3063 days ago and no results are posted on ClinicalTrials.gov.

Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects

NCT IDNCT02583451 ↗
SponsorEisai Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-01-31 (ACTUAL)
Reporting deadline2018-01-31 (completion + 365d)
Days overdue3063
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 20a6aa050d201504… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02583451. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →